Assessing the effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in Belgium by means of an extended SEIQRD model and public mobility data.
COVID-19 hospital length-of-stay
Compartmental SEIQRD model
Google Community Mobility data
Non-pharmaceutical interventions
SARS-CoV-2
Schools closure
Social contact effectivity
Journal
Epidemics
ISSN: 1878-0067
Titre abrégé: Epidemics
Pays: Netherlands
ID NLM: 101484711
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
21
07
2020
revised:
16
07
2021
accepted:
28
09
2021
pubmed:
15
10
2021
medline:
21
12
2021
entrez:
14
10
2021
Statut:
ppublish
Résumé
We present a compartmental extended SEIQRD metapopulation model for SARS-CoV-2 spread in Belgium. We demonstrate the robustness of the calibration procedure by calibrating the model using incrementally larger datasets and dissect the model results by computing the effective reproduction number at home, in workplaces, in schools, and during leisure activities. We find that schools and home contacts are important transmission pathways for SARS-CoV-2 under lockdown measures. School reopening has the potential to increase the effective reproduction number from R
Identifiants
pubmed: 34649183
pii: S1755-4365(21)00054-2
doi: 10.1016/j.epidem.2021.100505
pmc: PMC8487325
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100505Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Références
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Int J Environ Res Public Health. 2020 Oct 17;17(20):
pubmed: 33080869
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
J R Soc Interface. 2010 Jun 6;7(47):873-85
pubmed: 19892718
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Euro Surveill. 2020 Jan;25(4):
pubmed: 32019669
J Clin Med. 2020 Feb 17;9(2):
pubmed: 32079150
Lancet Microbe. 2021 Feb;2(2):e60-e69
pubmed: 33521709
PLoS One. 2012;7(11):e48695
pubmed: 23155399
Epidemiol Infect. 2020 Nov 13;148:e284
pubmed: 33183366
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
BMC Infect Dis. 2021 Jul 22;21(1):700
pubmed: 34294037
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
Lancet Infect Dis. 2021 Jan;21(1):52-58
pubmed: 33058797
Nat Commun. 2021 Mar 9;12(1):1524
pubmed: 33750778
Euro Surveill. 2022 Feb;27(7):
pubmed: 35177167
Epidemics. 2021 Jun;35:100449
pubmed: 33799289
Sci Rep. 2020 Dec 14;10(1):21885
pubmed: 33318521
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
J Math Biol. 1990;28(4):365-82
pubmed: 2117040
Epidemics. 2021 Dec;37:100490
pubmed: 34482186
Euro Surveill. 2022 Mar;27(9):
pubmed: 35241216
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
Clin Infect Dis. 2021 Nov 2;73(9):e2823-e2825
pubmed: 32964927
Arch Public Health. 2020 Nov 18;78(1):121
pubmed: 33292566
Clin Infect Dis. 2021 Jul 15;73(2):354-356
pubmed: 32887979
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200264
pubmed: 34053267
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415
pubmed: 32271722
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
Science. 2020 Oct 30;370(6516):527-529
pubmed: 33055131
PLoS Comput Biol. 2021 Feb 11;17(2):e1008559
pubmed: 33571188
Nat Commun. 2021 Feb 19;12(1):1162
pubmed: 33608522
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Nat Med. 2020 Apr;26(4):506-510
pubmed: 32284616
Wellcome Open Res. 2020 Apr 1;5:58
pubmed: 32685697
PLoS Med. 2008 Mar 25;5(3):e74
pubmed: 18366252